Patent US5580767A successfully refreshed from Google Patents.
US5580767A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Inhibition of influenza viruses by antisense oligonucleotides
Assignee: Ionis Pharmaceuticals Inc
•
Filing: 1991-08-13
•
Granted: 1996-12-03
•
Expires: 2011-08-13
Abstract
Abstract PCT No. PCT/US91/05742 Sec. 371 Date Sep. 22, 1992 Sec. 102(e) Date Sep. 22, 1992 PCT Filed Aug. 13, 1991 PCT Pub. No. WO92/03454 PCT Pub. Date Mar. 5, 1992Compositions and methods are provided for the treatment and diagnosis of influenza virus infections. In accordance with preferred embodiments, oligonucleotides and oligonucleotide analogs are provided which are specifically hybridizable with viral RNAs. The oligonucleotide comprises nucleotide units sufficient in identity and number to effect said specific hybridization. In other preferred embodiments, the oligonucleotides are specifically hybridizable with a transcription initiation site, a translation initiation site, 5'-untranslated sequences, 3'-untranslated sequences, and intron/exon junction of influenza virus mRNAs. In additional preferred embodiments, the oligonucleotides are specifically hybridizable with RNA sequences involved in splicing of the viral RNA, or in viral packaging. Methods of treating animals suffering from influenza virus infection are disclosed.
Inventors
- 👤 Lex M. Cowsert
- 👤 David J. Ecker
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-07 15:07
CPC Classifications
C; C12; C12N; C12N15/00; C12N15/09; C12N15/11; C12N15/113; C12N15/1131; A; A61; A61K; A61K38/00; A61K38/16; A61P; A61P31/00; A61P31/12; A61P31/14; A61P31/16; C07; C07K; C07K14/00; C07K14/005; C07K14/08; C07K14/11; C12N2310/00; C12N2310/10; C12N2310/13; C12N2310/30; C12N2310/31; C12N2310/315; C12N2310/32; C12N2310/321; C12N2310/322; C12N2310/35; C12N2310/352; C12N2310/3521; C12N2310/3527; C12N2310/353; C12N2310/3533; C12N2760/00; C12N2760/00011; C12N2760/16011; C12N2760/16111; C12N2760/16122
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
46 words
An oligonucleotide having SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7 or SEQ ID NO: 8, wherein at least some of the internucleotide linkages within said oligonucleotide are phosphorothioate linkages.
Claim 2
Dependent Claim
46 words
An oligonucleotide having SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7 or SEQ ID NO: 8, wherein at least some of the internucleotide linkages within said oligonucleotide are phosphorothioate linkages.
Claim 3
Dependent Claim
107 words
An oligonucleotide having SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 15, SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 20, SEQ ID NO: 21, SEQ ID NO: 22, SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 25, SEQ ID NO: 26, SEQ ID NO: 27, SEQ ID NO: 28, SEQ ID NO: 29, SEQ ID NO: 30, SEQ ID NO: 31 or SEQ ID NO: 32 SEQ., wherein at least some of the internucleotide linkages within said oligonucleotide are phosphorothioate linkages.
Claim 4
Dependent Claim
107 words
An oligonucleotide having SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 15, SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 20, SEQ ID NO: 21, SEQ ID NO: 22, SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 25, SEQ ID NO: 26, SEQ ID NO: 27, SEQ ID NO: 28, SEQ ID NO: 29, SEQ ID NO: 30, SEQ ID NO: 31 or SEQ ID NO: 32 SEQ., wherein at least some of the internucleotide linkages within said oligonucleotide are phosphorothioate linkages.
Claim 5
Independent Claim
69 words
A method of inhibiting influenza virus replication in cells in vitro by introducing an oligonucleotide having SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7 or SEQ ID NO: 8, wherein at least some of the internucleotide linkages within said oligonucleotide are phosphorothioate linkages, into said cells in an amount sufficient to inhibit replication.
Claim 6
Independent Claim
69 words
A method of inhibiting influenza virus replication in cells in vitro by introducing an oligonucleotide having SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7 or SEQ ID NO: 8, wherein at least some of the internucleotide linkages within said oligonucleotide are phosphorothioate linkages, into said cells in an amount sufficient to inhibit replication.
Claim 7
Independent Claim
130 words
A method of inhibiting influenza virus replication in cells in vitro by introducing an oligonucleotide having SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 15, SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 20, SEQ ID NO: 21, SEQ ID NO: 22, SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 25, SEQ ID NO: 26, SEQ ID NO: 27, SEQ ID NO: 28, SEQ ID NO: 29, SEQ ID NO: 30, SEQ ID NO: 31 or SEQ ID NO: 32 SEQ., wherein at least some of the internucleotide linkages within said oligonucleotide are phosphorothioate linkages, into said cells in an amount sufficient to inhibit replication.
Claim 8
Independent Claim
130 words
A method of inhibiting influenza virus replication in cells in vitro by introducing an oligonucleotide having SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 15, SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 20, SEQ ID NO: 21, SEQ ID NO: 22, SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 25, SEQ ID NO: 26, SEQ ID NO: 27, SEQ ID NO: 28, SEQ ID NO: 29, SEQ ID NO: 30, SEQ ID NO: 31 or SEQ ID NO: 32 SEQ., wherein at least some of the internucleotide linkages within said oligonucleotide are phosphorothioate linkages, into said cells in an amount sufficient to inhibit replication.
References Cited (Backward Citations)
EP0081099A2
Cited
US4689320A
Cited
EP0169787B1
Cited
US5194428A
Cited
US5004810A
Cited
US5166195A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1999-12-03 | 2000-06-03 | 2000-12-03 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2003-12-03 | 2004-06-03 | 2004-12-03 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2007-12-03 | 2008-06-03 | 2008-12-03 | $7700.00 | Window Closed / Lapsed |